Ionis Pharmaceuticals, Inc. Cost-method Investments, Realized Losses
Ionis Pharmaceuticals, Inc. (IONS) reported Cost-method Investments, Realized Losses of $267.00 thousand for the 9-month period ending 2011-09-30, per its 10-Q filed 2011-11-08.
Discontinued › Income Statement › Other Income
us-gaap:CostMethodInvestmentsRealizedLosses · last filed 2011-11-08
- Ionis Pharmaceuticals, Inc. cost-method investments, realized losses for the quarter ending 2011-09-30 was -$18.00K.
| Period end | Cost-method Investments, Realized Losses 3 month | Cost-method Investments, Realized Losses 6 month | Cost-method Investments, Realized Losses 9 month |
|---|---|---|---|
| 2011-09-30 | -$18.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-08 | $267.00K 10-Q · filed 2011-11-08 | |
| 2011-06-30 | $285.00K 10-Q · filed 2011-08-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 | |
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |
| Amneal Pharmaceuticals, Inc. (AMRX) | $6.326B | 25.62 | |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |